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Policy commentary 
Social prescribing 'plus': a model of asset-based 
collaborative innovation? 
Chris Dayson* 
CRESR, Sheffield Hallam University 
Abstract 
Social prescribing is a current UK social policy phenomenon but to what extent does it 
represent a substantive change in the way policymakers think about services for 
people with multiple and complex needs? I draw on several local studies of social 
prescribing initiatives to argue that cautious optimism is merited: through the idea of 
social prescribing 'plus' key actors in a number of localities have embraced the 
principles of asset-based working and collaborative innovation to achieve real change 
in policy and practice. However, policy interest in social prescribing cannot be 
decoupled from the public sector austerity and transformation agenda, and the true 
testing ground will be how local policymakers develop services in future: will they draw 
on the asset-based collaborative principles of social prescribing 'plus'; or will it lead to 
expectations that people and communities do more for themselves without the 
necessary investment in this alternate model of welfare. 
Keywords: Social prescribing; asset-based approaches; collaborative innovation. 
 
Introduction 
Social prescribing has become something of a social policy phenomenon in the UK in 
recent years. If your local area hasn't 'got it' already then you can be certain that key 
players from the local voluntary and community sector will be lobbying health and 
social care policymakers to get it up and running sooner rather than later. But is it just 
the latest 'shiny new policy thing' that will come and go before too or long or does it 
represent a more substantive change in the way policymakers think about the design 
and delivery of services for people with multiple and complex needs? This policy 
commentary draws on more than four years' experience of research and evaluation 
with social prescribing initiatives at an area level, and parallel engagement with 
accompanying policy debates,1 to lay some groundwork for addressing this question. I 
do this by introducing the idea of social prescribing 'plus' and drawing together two 
emergent theoretical concepts - asset-based approaches to health and care; and 
collaborative innovation - to reframe social prescribing in the context of broader 
debates and competing paradigms of public administration. In the process, I hope to 
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stimulate discussion and debate about social prescribing, its place in systems of health 
and social care service delivery, and the broader processes and principles of public 
service transformation.  
What is social prescribing? 
Social prescribing is a recent innovation in public health and social care services 
through which medical and care professionals - including General Practitioners (GPs), 
mental health practitioners, nurses and social workers - refer patients with complex 
health conditions to sources of social support provided by local voluntary and 
community organisations (South et al, 2008; Kimberlee, 2015; Dayson, 2017). The 
overarching aims of social prescribing are twofold: to reduce demand on primary, 
secondary and social care services; and to improve personal well-being and a wider 
range of social determinants of health such as isolation, self-esteem and social 
connectedness. In its early days social prescribing was typically delivered from the 
'bottom-up' by local neighbourhood and  community organisations and through 
volunteers working with single GPs or small groups of practices to link patients with 
existing activities and opportunities in their community. This work sometimes received 
small amounts of public funding but was not considered part of mainstream statutory 
service delivery. However, the period since 2012 has seen the emergence of social 
prescribing as a 'top down' policy agenda, with large 'services' increasingly being 
commissioned as part of area level health and social care integration and 
transformation programmes (see Hughes, 2017, for a broader discussion of this policy 
discourse). Despite this mainstreaming of social prescribing there remains 
considerable difference in the ways in which it is being implemented across the UK 
with local variations according to level and source of funding, model of commissioning, 
the targeting and identification of service users, geographic coverage, referral sources, 
and the breadth of 'prescribed' activities. A more detailed overview of these variations 
is provided in table 1. 
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Table 1: Variations in social prescribing delivery models 
Aspect of variation Nature Summary 
Funding and 
resources 
 Mainstream health and social care 
budgets  Other non-recurrent public funds  Independent and charitable funds  Social investment (inc social impact 
bonds) 
In most areas social prescribing is being funded through mainstream health and 
social care budgets, including the 'Better Care Fund', the central Government 
funding 'pot' for health and social care transformation; and the 'Transformation 
Challenge Award' which provides additional funding to support area level 
transformation. However, social prescribing is not universally funded through 
these sources and other funding sources have been utilised, including grants 
from independent charitable funders and social investment vehicles such as 
social impact bonds. In addition, a Department of Health funding scheme for 
social prescribing has recently been launched. 
Commissioning and 
delivery model  
 Advisors handle referral process 
- Paid staff 
- Volunteers  Lead provider/Single point of contact  Consortia models 
- Needs led 
- Area specific 
A core component of a majority of social prescribing models is a team of 
'advisors' or 'link workers' liaising with medical professionals to take 'referrals-in' 
of patients in need of a social prescription, identify their support needs and 
requirements, and make 'referrals-out'  to appropriate voluntary and community 
activity. The advisor is usually a paid member of staff but in some case this role 
is taken or supported by volunteers. 
A number of different commissioning models have been developed for social 
prescribing. Typically, it is commissioned through a lead provider or single point 
of contact (usually a local voluntary organisation) that manages the advisors 
and associated referral processes. In some cases a consortia of local 
organisations has been commissioned with specific organisations leading on 
defined geographic areas or types of support need. 
Targeting and 
identifying service 
users 
 Risk stratification  Needs assessment  Clinical discretion 
A variety of mechanisms for have been developed for targeting and identifying 
patients in need of a 'social prescription'. In some areas a 'risk stratification' 
model is used to identify patients based on their level of clinical need while 
others rely on less formal needs assessments and the discretion of clinicians to 
identify the most appropriate patients. 
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Geographic 
coverage 
 LA or CGG wide  Community or Neighbourhood  Groups of General Practices  Single General Practices 
The majority of the recently developed 'top-down' social prescribing services 
cover a scale that is contiguous with local administrative boundaries: typically a 
Local Authority or NHS CCG area. There are still however some examples of 
'bottom-up' social prescribing initiatives being delivered at smaller geographic 
scales. Often these are a partnership between a local community or 
neighbourhood level 'anchor' organisation and a small number of General 
Practices. 
Referral Sources  Primary care 
- GPs 
- Mental health services 
- Pharmacy  Secondary care  Community/self-referral 
'Referral-in' to social prescribing services is usually focussed on General Practice 
with formal mechanisms for Practice staff (GPs, nurses and administrative staff) 
to refer eligible patients to advisors from the local service. However, there are 
range of local variations in the types of referral pathways available. These 
include other primary care services, such as mental health services and 
pharmacists, secondary care, and referrals from community sources (including 
self-referral). 
Prescribed activities  Menu of new services  Commissioned  voluntary/community 
services   Non-statutory voluntary/community 
services  Statutory services 
The types of activities that people can be 'referred-out' to from social prescribing 
depend on what is available locally. In some areas 'menus' of services have 
been specifically developed to meet the needs of patients referred to social 
prescribing. However, in many areas social prescribing relies on existing 
activities and services provided by local voluntary and community organisations, 
including those commissioned by statutory bodies, wider non-statutory provision 
and volunteer led organisations and groups. Many social prescribing services 
also refer to statutory and public sector services when specific needs and gaps 
in support are identified. 
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Given the growing heterogeneity of social prescribing delivery models and the aims 
and assumptions that underpin them it is increasingly important to differentiate 
between approaches to social prescribing, in particular the breadth and depth of 
models developed in different localities and for different types of patient. An early 
attempt to  codify approaches to social prescribing by Kimberlee (2015) laid them out 
on a continuum, from 'light' at one end through to 'holistic' on the other. However, as 
social prescribing has become part of mainstream commissioned services most 
approaches could be described as 'holistic', and there is a need to distinguish yet 
further between the these 'holistic' approaches. In response, the idea of social 
prescribing 'plus' has emerged from practice as a means of identifying the most 
extensive and embedded models and setting them apart from other 'holistic' 
approaches.  
Although social prescribing 'plus' is an emergent concept that has not been formally 
defined, there are a number of key features and practices that set it apart from other 
approaches.   Broad geographic coverage: the service will cover a large geographic area that is 
contiguous with a local authority or NHS Clinical Commissioning Group (CCG) 
boundary.  Multiple clearly delineated referral pathways from a variety of health settings: 
including from GPs and other practitioners at a practice level, statutory mental 
health services, and secondary care.  A range of social prescribing specific services and activities are available: social 
prescribing service users are able to choose from a 'menu' of services that have 
been specifically developed for the service. These services will receive funding to 
ensure they can meet the demand from social prescribing service users. Where 
appropriate, service users will be supported to develop their own self-sustaining 
groups or activities.  Significant long term investment of strategic funds across multiple service 
areas: local policymakers will view social prescribing as model for strategic 
commissioning with the voluntary sector and ensure funding is available over a 
long time period (three years or more) following a successful pilot phase. 
Although an example of social prescribing 'plus' would not be expected to exhibit all 
of these characteristics, it should exhibit a number in combination, and include a 
commitment to resourcing financially both the referral processes through which service 
users are identified and directed to support, and the services and activities to which 
they are referred. In areas where social prescribing 'plus' has been implemented it has 
necessitated step change in local commissioning practices that involve the local 
voluntary and community sector, from ad hoc and piecemeal awarding of grants and 
short term contracts, to a more strategic approach. An overview of one prominent 
example of social prescribing 'plus' - the Rotherham Social Prescribing Service - is 
provided in table 2 for illustrative purposes. 
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Table 2: Social prescribing 'plus' in practice: a case study of the Rotherham Social Prescribing Service 
 Rotherham Social Prescribing Service 
1. Coverage The service covers the whole local authority/CCG area of Rotherham.  
Every GP practice in the area makes referrals to the service. 
Direct referral from statutory mental health services also possible. 
2. Pathways Two separate pathways from primary care and statutory mental health services:   Patients with long term health conditions who are eligible for Integrated Case Management are referred by their 
GP following discussions in case management meetings.  Patients in mental health 'clusters' 4, 7 and 11 are referred following discussion with their mental health case 
worker. 
3. Services and activities A 'menu' of 20-30 services and activities is available for social prescribing service users to tailor individual packages 
of support from a range of voluntary and community sector providers. 
Funding for these services is provided through the main social prescribing contract but awarded in the form of small 
grants to provider organisations.  
Service users are referred on to 'mainstream' voluntary and public sector services as appropriate. Support is also 
provided for service users to develop their own self-sustaining activities. 
4.Funding and commissioning 
model 
Social prescribing is viewed by the CCG as a strategic approach to involving the local voluntary and community sector 
in mainstream primary and community health services and they have developed a bespoke commissioning model to 
support this. 
Voluntary Action Rotherham (VAR) - the local voluntary sector umbrella body - holds two contracts for the delivery of 
social prescribing with the CCG (one covering long term conditions; one covering mental health). Each contract 
includes provision for small grants that are awarded - 'micro-commissioned' - to voluntary and community sector 
providers on a competitive basis. 
Grant holders also have access to additional capacity building support from VAR. Support is also provided for service 
users to apply for funding to develop their own self-sustaining activities. 
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Framing social prescribing 'plus' from a policy perspective 
Social prescribing is variously described as an 'asset-based approach' and a 'social 
innovation', but with limited engagement with the theoretical underpinnings of these 
terms or the processes associated with them. The following sections aim to provide 
some theoretical substance to the idea of social prescribing 'plus', first as an asset-
based approach and then as an example of collaborative innovation, before bringing 
them together in a re-framing of social prescribing 'plus' as a model of policy innovation 
that combines both sets of ideas. 
The possibilities and pitfalls of asset-based approaches to health and care 
Although social prescribing is an important social policy development in and of 
itself, its rise to prominence needs to be understood in the context of the wider 
propagation of 'asset-based' approaches to health and care which have emerged in the 
past 10-15 years as a way of increasing equity in health.  As a discourse it has 
permeated practice, policy and academia as a critical counterpoint to the (perceived) 
persistence of deficit-based approaches to health which focus on 'problems' that need 
to be 'solved' by health professionals and policymakers (Durie and Wyatt, 2013). The 
implicit assumption of deficit approaches is that individuals and communities do not 
have the necessary resources or expertise to address health problems themselves 
(Warr et al, 2013). In contrast asset-based approaches aim to promote and develop 
the capabilities and capacities that support good health and well-being whilst 
ameliorating the symptoms and consequences of poor health (Brooks and Kendall, 
2013; Morgan and Zigilo, 2007).  Morgan and Ziglio (2007: 18) describe a health asset 
as: 
"…any factor (or resource), which enhances the ability of individuals, groups, 
communities, populations, social systems and/or communities to maintain and 
sustain health and well-being and help to reduce health inequalities. These 
assets can operate at the level of the individual, group, community and/or 
population as protective (or promoting) factors to buffer against life's stresses." 
In essence asset-based approaches seek to redress the balance between meeting 
the needs of people and communities and nurturing their strengths (assets) in support 
of better health and well-being (McLean, 2011).  
Although the rise to prominence of asset based approaches is evident in 
international, national and local policy developments (see e.g. WHO, 2012a and 
2012b; NHS England, 2014; Department of Health, 2014; NHS North West, 2010) 
their practical implementation is in its infancy. They have typically been delivered 
through small projects or pilots rather than large programmes or system wide 
approaches to implementation. As such, evidence of their efficacy in addressing health 
inequalities is limited (Hopkins and Rippon, 2015) and very little has been written 
about the characteristics of a successful asset based approach. An exception is 
Morgan (2014), who proposed a set of principles against which the practical 
implementation of asset-based approaches can be assessed. An overview is provided 
in table 3 along with discussion of the extent to which different approaches to social 
prescribing meet these criteria. It indicates that whilst much of social prescribing 
practice mirrors the criteria of effective asset-based working it is social prescribing 
'plus' that is most closely aligned with the principles Morgan (ibid) proposes. 
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Table 3: An assessment of social prescribing as an asset-based approach 
 Morgan's (2014) criteria for asset-based 
approaches 
Social prescribing Social prescribing 'plus' 
1 Health and social care policymakers prioritise 
approaches that emphasise building positive 
well-being and associated psychosocial 
resources such as self-efficacy, self-esteem and 
resilience. 
Improving personal well-being is at the core of 
nearly every model of social prescribing.  
Policymakers who make a commitment to 
developing and implementing social prescribing 
are acknowledging - whether implicitly or 
explicitly - the importance of well-being and 
wider psychosocial resources as determinants 
of positive health. 
In models of social prescribing 'plus' 
policymakers have made a commitment to 
improving well-being and other psycho-social as 
part of a commissioning strategy for 
mainstream service delivery budgets. 
2 Individuals and local communities are involved 
effectively and appropriately in the health 
development process by building on and 
developing individual and community 
capabilities and capacities. 
Most social prescribing models take a user-
centred approach. Referrals-out to voluntary 
and community services are based on their 
personal interests and the types of support 
patients say they want and need. 
Models of social prescribing 'plus' are based on 
the principals of co-production. All stakeholders, 
including service users and community 
providers in receipt of referrals, will be involved 
in the design and review of the service at key 
stages of its development and implementation. 
3 Individuals are enabled to connect with 
community and broader society, including 
through solutions and activities that build social 
capital and utilise and develop voluntary 
organisations and community groups. 
In most cases engagement with social 
prescribing results in a 'referral-out' to social 
activities at a community level. Where 
necessary support is provided to enable people 
to engage in a way that is appropriate and 
proportionate to their circumstances. There are 
an increasing number of examples of social 
prescribing service users going on to become 
volunteers, including setting up their own social 
and peer-led groups. 
In social prescribing 'plus' commissioners will 
have a strong understanding of service users' 
needs and have mapped these against the 
availability of services and activities at a 
community level.  
Where gaps in provision are identified 
commissioners will provide resources to build 
the capacity and capabilities necessary for 
needs to be met effectively. 
4 Key stakeholders work in a decision-focused, 
multi-professional and multidisciplinary way, 
including through integration of teams working 
There are some examples of social prescribing 
being embedded in wider models of multi-
disciplinary teams of health and social care 
Social prescribing 'plus' is often part of a wider 
commitment to integrated multi-disciplinary 
working at a community level. Social prescribing 
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in health, social care and community 
development. 
professionals, including as part of 'case 
management'. However, this is not the norm 
and the engagement of social prescribing 
advisors with other health and social care 
professionals is often ad hoc and reliant on 
informal personal relationships rather than 
formal institutional links.  
advisors will work closely with health, social 
care and mental health professionals from 
statutory bodies to identify people for whom 
social prescribing might be appropriate, 
develop support plans and review progress. 
5 Investment in asset-based working is from a 
variety of sources (statutory and non-statutory) 
through a multi-method, evidence-based 
approach that prioritises effective evaluation of 
which types of assets and interventions support 
positive well-being, resilience and social capital. 
Funding for social prescribing varies area by 
area but the majority of funding is from pooled 
health and social care budgets, in particular the 
'Better Care Fund' which was designed to 
support the transformation and integration of 
health and social care at a local level. However, 
many social prescribing services have time 
limited funding (1-3 years) are viewed as pilots 
rather than part of mainstream services. 
Although there is no national social prescribing 
research programme in many areas local 
evaluations of social prescribing services have 
been commissioned. Typically these focus on 
measuring patients' progress against measures 
of well-being and associated psychosocial 
factors but their designs often fall short of the 
highest 'standards of evidence' and are 
inhibited by the 'real world' circumstances of 
their implementation. 
Models of social prescribing 'plus' will involve a 
long term investment in social prescribing (3 
years or more) as part of wider commissioning 
strategies for health, mental health and social 
care services. Funding for social prescribing 
delivery will be from a combination of pooled 
budgets such as the Better Care Fund and 
mainstream service budgets. 
Most examples of social prescribing 'plus' also 
include an embedded longitudinal evaluation 
that provides timely and useful information to 
inform service delivery and commissioning. 
Source: Adapted from Morgan (2014) 
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Processes of collaborative innovation 
Social prescribing can be described as a 'social innovation' in that it is a new idea 
that both addresses unmet social needs and works effectively to create social value 
(Mulgan, 2007; see also Dayson, 2017 for a broader discussion of social prescribing 
as a social innovation through which social value is created). However, to date, there 
has been little discussion of the processes of social innovation through which social 
prescribing has been adopted and diffused across the UK. The idea of collaborative 
innovation is helpful here because it highlights the importance of multi-actor 
collaboration during the development and implementation of a new policy (Hartley et al, 
2013). In particular, it emphasises the involvement of 'downstream' actors, including 
voluntary and community organisations and service users, alongside 'upstream' policy 
stakeholders, in the creation and diffusion of novel and bold solutions to previously 
intractable and 'wicked' problems (Ansell et al, 2017). This requires a genuine 
commitment to multi-stakeholder involvement throughout the design and 
implementation of a policy: from understanding problems and challenges; to 
developing and testing new ideas; and implementing, adapting and diffusing successful 
approaches (see Sorensen and Torfing, 2015, for a broader discussion).  
Proponents of collaborative innovation situate their arguments in a critique of the 
New Public Management approaches to public administration that have been 
predominant since the 1990s in many western democracies. Whereas New Public 
Management advocated quasi-markets through which public services were contracted 
out and imported other private sector mechanisms such as performance targets and 
performance related pay (see e.g. Hood, 1991; Osborne and Gaebler, 1992); 
collaborative innovation and associated New Public Governance approaches (see 
Osborne, 2006 and 2010 for a broader discussion) emphasise a more collaborative 
cross-disciplinary and inter-organisational approach focussed on complex ('wicked') 
problems and the development of bold new solutions to meeting them. Advocates of 
this type of approach argue that they are more likely to produce public innovations that 
lead to effective, efficient and higher quality services (Sorensen and Torfing, 2015). 
Table 4 draws on the case study of the Rotherham Social Prescribing Service to 
demonstrate the extent to which the development and implementation of social 
prescribing 'plus' exhibited the characteristics of collaborative innovation. This example 
highlights the extent of the collaborative processes involved in developing and 
implementing a social prescribing 'plus' model. It demonstrates how key actors in the 
social prescribing service were able to form a coalition of 'upstream' and 'downstream' 
actors from the public, voluntary and community sectors to first understand problems 
and challenges associated with people multiple and complex long term conditions; 
then develop, test and implement series of new ideas for addressing their needs; 
before diffusing the approach to other areas of service delivery (mental health) and 
other parts of the country. 
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Table 4: Social prescribing 'plus' as a process of collaborative innovation: a case study of the Rotherham Social Prescribing Service 
1. Understanding problems and challenges 
The service was borne out of discussions between health commissioners and representatives of the 
voluntary and community sector (VCS) in 2011/12 about how the VCS could better support health service 
priorities. Health commissioners challenged the VCS representatives to develop a new approach that would 
help prevent unplanned and unnecessary use of secondary care by people with complex long term 
conditions by addressing their social needs. 
2. Developing and testing new ideas 
A comprehensive social prescribing model was developed by the VCS representatives in consultation with 
key stakeholders: commissioners, GPs, the broader VCS, and service users. A business case was developed 
that emphasised the need fund both the referral process and the services that would be described. Health 
commissioners identified a source of non-recurrent funds through which to support a two year pilot 
between 2012/13 and 2013/14. 
3. Implementing solutions 
The pilot was implemented on a 'test and learn' basis and delivery adapted regularly in response to 
feedback from GPs, service users, VCS organisations and the findings of an independent formative 
evaluation. Evidence about the outcomes and impact of the pilot was shared with commissioners both 
formally (e.g. through evaluation reports and presentations) and informally (e.g. through discussion and the 
sharing of stories). 
4. Diffusing successful approaches 
The two year pilot was judged to have been successful and mainstream funding provided to support 
ongoing delivery (from 2014/15 onwards). Learning was diffused locally and led to the development of 
'sister' services to support people with mental health conditions and carers of dementia patients. It was 
also shared with other areas seeking to develop their own approaches to social prescribing, and nationally, 
with policymakers in the NHS and Department of Health aiming to embed social prescribing more 
systematically across health and social care services.  
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Reframing social prescribing 'plus' as a model of asset-based collaborative policy 
innovation 
There are clear synergies between the principles of asset-based health and care 
and the ideas associated with collaborative innovation, many of which are manifest in 
the development and implementation of social prescribing 'plus' in the Rotherham 
example. I therefore propose a reframing of social prescribing 'plus' as a model of 
asset-based collaborative policy innovation based on the following principles. 
1. Placing service users at the centre of the design and delivery of social prescribing 
Service users play a central role in understanding needs - their own needs and the 
needs of others - and are provided with tailored support to address those needs. 
The 'expertise' of service users should be valued and recognised throughout the 
social prescribing development and implementation process, with regular 
opportunities to provide feedback and shape the future delivery of the service.  
2. Harnessing and investing in voluntary and community assets through social 
prescribing 
Voluntary and community organisations should be key stakeholders in the design 
and delivery of social prescribing services. Like service users they should be 
considered an asset whose expertise and insights are valued at all stages of the 
development and implementation process. There should also be a commitment to 
invest financially in organisations where their involvement in social prescribing 
requires them to deliver additional services or increase capacity in existing 
services. A further commitment to building the capacity of voluntary organisations 
involved in the delivery of social prescribing, including support for new user-led 
groups and activities to develop, will be essential if a voluntary and community 
asset base capable of supporting social prescribing is to be sustained.  
3. Taking on board the needs and views of professionals involved in social 
prescribing 
The development and implementation of social prescribing should also be 
responsive to the needs and view of professionals involved in social prescribing. 
For social prescribing to work effectively referral processes and feedback 
mechanisms should be embedded in existing systems of working such as case 
management and broader service pathways and transition processes. 
4. Multi-stakeholder and inter-disciplinary collaboration throughout the development 
and implementation of social prescribing 
Principles 1-3 highlight the multi-stakeholder and inter-disciplinary nature of social 
prescribing. Ongoing and effective collaboration between stakeholders and 
disciplines, based on mutual trust and understanding, is an essential component 
in the effective development and implementation of social prescribing. 
5. Understanding the delivery of social prescribing as a process of adaptive 
implementation 
As a relatively new phenomenon social prescribing services should be developed 
and implemented adaptively on a 'test and learn' basis. This requires 
commissioners to accept refinements to what and how a service delivers based on 
lessons learned during its implementation rather than focus on predefined 
performance targets. It also requires organisations involved in the delivery of social 
prescribing, and wider stakeholders, to feel confident that they can have a dialogue 
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with commissioners about what needs to change without adversely affecting how 
'performance' is viewed. 
Although these principles have been framed in the context of the development and 
implementation of social prescribing they ought to have broader applicability to other 
areas of public service delivery that require the involvement of or engagement with a 
broad range of upstream and downstream stakeholder perspectives. One area in which 
they ought to resonate particularly strongly is service areas embarking on processes of 
transformation, for it is here that the need to provide innovative policy solutions and 
collaborate with key stakeholders is most clearly evident. 
Conclusion 
Through this policy commentary I have documented the emergence of social 
prescribing policy and introduced the idea of social prescribing 'plus' as an example of 
how the policy could evolve in the future. In doing so I have reframed social prescribing 
in the context of a broader body of literature on asset-based and collaborative 
approaches to designing and implementing innovative ways to support people with 
multiple and complex needs through integrated health and social care services. 
Although the ideas and arguments I have proposed require further empirical and 
theoretical elaboration they will hopefully provide a start point for critical reflection and 
debate about if and why social prescribing and associated approaches should become 
a permanent and central feature of health and social care services across the UK. They 
ought also to feed into to wider debates about how public sector bodies involve 
voluntary and community organisations, and the people they represent, in the 
transformation and commissioning of public services. 
Returning to my original question of whether social prescribing represents a more 
substantive step-change in the way policymakers think about the design and delivery 
of health and social care policy, the unsatisfactory answer has to be that the jury is still 
out. The evidence suggest cautious optimism is merited: through social prescribing 
'plus' in particular policymakers in a number of localities have embraced the principles 
of asset-based working and collaborative innovation but whether this amounts to a 
genuine step-change in their approach will need to be assessed over the longer term. 
The current interest in social prescribing cannot be decoupled from the policy and 
politics of public sector austerity and transformation and a number of commentators 
have argued that asset-based approaches could become a smokescreen for reductions 
in statutory provision of public health, care and welfare services, alongside further 
marketisation of public services, and the withdrawal of the social rights of citizens 
(Friedli, 2013). These critics suggest that only when asset-based approaches like social 
prescribing are adopted and invested in as a mechanism for reducing barriers to the 
resources necessary for good health, and framed as a core strategy for increasing 
equity in health (South et al, 2013), should they be embraced as an opportunity to 
increase the involvement of individuals, communities and organisations that represent 
and support them, in public services.  
In this vein, it seems the true testing ground for social prescribing will be how local 
policymakers develop policy and commission services moving forward: will their 
approaches draw on the asset-based collaborative principles that are evident in the 
development and implementation of social prescribing 'plus'; or will social prescribing 
become a convenient way of framing an expectation that people and communities 
need to do more to help themselves, without significant investment in the capacity and 
capabilities necessary to support this alternate model of welfare.  In practice, this will 
require a shift in the debate about social prescribing at local and national level, from 
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asking "how can we do social prescribing" to "what does it mean to do it"? I suggest 
that only if this happens, and asset-based collaboration is embraced, will the potential 
of social prescribing 'plus' to embody a step-change in health social care policy be 
realised. 
Notes 
1 The author has been involved formally in evaluations of four local social prescribing 
programmes and participated in numerous policy fora aimed at developing local 
approaches to social prescribing across the UK. 
* Correspondence address: Chris Dayson, CRESR, Sheffield Hallam University, Unit 10, 
Science Park, Howard Street, Sheffield, S1 1WB. Email: c.dayson@shu.ac.uk  
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